PD-E2: a nano-scaled delivery for estradiol to decrease uterus damage and increase bone mineral density
article
OA: closed
CC0
Abstract
PD-E2 was capable of simultaneously blocking bone loss and downregulating the expression of ALP in the serum, which made serum ALP a potential biomarker for monitoring the bone health of menopause women clinically.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (23)
- W1939368657 via openalex
- W2004726561 via openalex
- W2034189578 via openalex
- W2051026082 via openalex
- W2145076004 via openalex
- W2322280164 via openalex
- W2601243811 via openalex
- W2964886730 via openalex
- W3020862479 via openalex
- W3025794326 via openalex
- W3158358107 via openalex
- W4321379014 via openalex
- W4362657702 via openalex
- W4376127590 via openalex
- W4378071555 via openalex
- W4385406656 via openalex
- W4388363149 via openalex
- W4390666418 via openalex
- W4390988822 via openalex
- W4392160834 via openalex
- W4392372703 via openalex
- W4396577061 via openalex
- W4400472911 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK